Mangoceuticals, Inc.

8-K Entered a material agreement; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Jul 30, 2026 8-K Entered a material agreement; Unregistered sale of equity Jul 2, 2026 10-Q Quarter ended 2026-03-31 May 19, 2026 10-K Fiscal year ended 2025-12-31 Apr 1, 2026 8-K Director or officer change; Regulation FD disclosure Mar 17, 2026 8-K Regulation FD disclosure Feb 23, 2026 8-K Regulation FD disclosure Feb 19, 2026 8-K Delisting notice or listing-rule failure Feb 6, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 19, 2025 8-K Entered a material agreement; Other events Dec 19, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 10, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q/A Quarter ended 2025-06-30 Nov 14, 2025 8-K Other events Nov 14, 2025 8-K Other events Nov 13, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change Oct 29, 2025 8-K Director or officer change Sep 12, 2025 8-K Entered a material agreement; Unregistered sale of equity Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Unregistered sale of equity Aug 4, 2025 8-K Entered a material agreement; Unregistered sale of equity Jul 23, 2025 8-K Amended charter or bylaws Jul 10, 2025 8-K Director or officer change Jul 3, 2025 8-K Unregistered sale of equity Jun 10, 2025 8-K Entered a material agreement; Unregistered sale of equity May 30, 2025 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition May 23, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events May 6, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Apr 25, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 17, 2025 8-K Director or officer change Apr 11, 2025 8-K Unregistered sale of equity Apr 8, 2025 8-K Unregistered sale of equity Apr 2, 2025 8-K Unregistered sale of equity Mar 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Mar 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results Mar 19, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 19, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 12, 2025 8-K Other events Feb 12, 2025